CausalSentinel

Protein Dossier — AZU1 (Azurocidin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Heel bone mineral density (BMD) T-score automated 0.101 0.016 2.28e-10 Wald ratio 1 cis NA
Eye problems or disorders: Glaucoma 0.248 0.0813 0.00229 Wald ratio 1 cis NA
Non-cancer illness code self-reported: chronic obstructive airways disease or copd 0.404 0.145 0.0054 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoarthritis -0.13 0.0472 0.006 Wald ratio 1 cis NA
Diagnoses - main ICD10: D25 Leiomyoma of uterus -0.464 0.18 0.0102 Wald ratio 1 cis NA
Hearing difficulty or problems: Yes -0.0559 0.0226 0.0133 Wald ratio 1 cis NA
Fasting glucose 0.0509 0.0218 0.0193 Wald ratio 1 cis NA
Creatinine (enzymatic) in urine -0.0268 0.0118 0.0238 Wald ratio 1 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine -0.259 0.114 0.0238 Wald ratio 1 cis NA
Eczema -0.215 0.101 0.0337 Wald ratio 1 cis NA
Non-cancer illness code self-reported: ankylosing spondylitis 0.359 0.169 0.0338 Wald ratio 1 cis NA
Paget’s disease 0.665 0.314 0.0342 Wald ratio 1 cis NA
…and 95 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2751_16_2 Azurocidin Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

62 association rows across 38 traits (62 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
MPO/PRTN3 protein level ratio 3e-939 rs12052108 1 GCST90315492 no MR -> candidate analysis
LCN2/PRTN3 protein level ratio 7e-873 rs12052108 1 GCST90315307 no MR -> candidate analysis
Circulating PRTN3 levels 1e-838 rs61242663 2 GCST90859963 no MR -> candidate analysis
Myeloblastin levels 1e-243 rs2074639 4 GCST90248550 no MR -> candidate analysis
Circulating AZU1 levels 4e-226 rs138032111 5 GCST90859945 no MR -> candidate analysis
AZU1 protein levels 2e-204 rs138032111 2 GCST90468408 no MR -> candidate analysis
Myeloblastin levels (PRTN3.3514.49.2) 8e-110 rs10425544 3 GCST90241987 no MR -> candidate analysis
Neutrophil forward scatter 2e-82 rs7254911 1 GCST90281224 no MR -> candidate analysis
Hematological traits (multi-trait analysis) 2e-54 rs76427287 1 GCST90838669 no MR -> candidate analysis
Neutrophil side scatter distribution width 6e-54 rs138303849 1 GCST90281225 no MR -> candidate analysis
Neutrophil side scatter 6e-52 rs76427287 1 GCST90281222 no MR -> candidate analysis
Neutrophil side fluorescence 1e-45 rs7254911 1 GCST90281223 no MR -> candidate analysis
…and 26 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 259 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
low tension glaucoma 0.278 common-variant locus no MR -> candidate analysis
anti-neutrophil antibody associated vasculitis 0.073 common-variant locus no MR -> candidate analysis
open-angle glaucoma 0.042 common-variant locus no MR -> candidate analysis
Abnormality of refraction 0.035 common-variant locus no MR -> candidate analysis
gestational diabetes 0.035 common-variant locus no MR -> candidate analysis

Of the 5 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=7.5e-09, LOEUF=1.7 — LoF-tolerant
GWAS Catalog 126 unique SNPs / 304 rows
ClinVar 100 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance